Abstract #0501

Multimodal Imaging of Vascularity and Drug Delivery in GBM Patients Treated with Anti-angiogenesis Inhibitor

Yi-Fen Yen¹, Jayashree Kalpathy-Cramer¹, Ciprian Catana¹, Xiao Da², Yangming Ou¹, Andrew L. Beers¹, Jacob Hooker¹, Bruce Rosen¹, Tracy Batchelor³, and Elizabeth R. Gerstner³

¹Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA, United States, ²Functional Neuroimaging Laboratory, Brigham and Women’s Hospital, Boston, MA, United States, ³Department of Neuro-oncology, Massachusetts General Hospital, Boston, MA, United States

Anti-angiogenic agents can decrease vessel permeability and perfusion, raising concerns that these agents may also decrease blood brain barrier penetration of concomitantly administered chemotherapy. Using MR-PET multimodal imaging, we found radiolabeled temozolomide correlated with permeability and perfusion in patients with recurrent GBM treated with bevacizumab. MR assessment of vascularity may be a surrogate marker for concomitant drug delivery.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.